Allergy to acetylsalicylic acid among patients with acute coronary syndrome
Among patients with acute coronary syndrome, for whom ASA may decrease morbidity and mortality (odds ratio 0.75),[2][1] a short but detailed history of reported adverse effects may allow clinicians to safely administer ASA. Patients with AERD report adverse reactions to ASA, asthma, and recurrent
Authors
- Ana Maria Copaescu (ORCID: https://orcid.org/0000-0002-9183-5032)
- A Haddad
- Adhora Mir
Institutions
- Western University (CA)
- McGill University Health Centre (CA)
- McGill University (CA)
Publication Details
- Journal
- Canadian Medical Association Journal
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1503/cmaj.250486
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00